Senate committee approves pharmacy rule rewrite but removes two compounding labeling subsections after stakeholder concerns

The Idaho Senate Health and Welfare Committee on Jan. 14 approved a rewrite of the Idaho State Board of Pharmacy rules but removed two specific labeling subsections after late stakeholder concerns about compounding and federal guidance.

Nikki Chopsky, bureau chief of health professions at the Division of Occupational and Professional Licenses and executive officer for the Idaho State Board of Pharmacy, told the committee the board conducted five public meetings, two negotiated-rulemaking hearings and one public hearing while drafting the pending rule docket (24-3601-2402). “Representatives from both state pharmacy associations were included in the process,” Chopsky said, and the board made “more than 35 changes” in the chapter to reduce duplication with statute and move toward a standard-of-care regulatory approach.

The committee earlier took no action on a related temporary-rule docket (24-3601-2401). Senator Sandra Harris moved, and Senator…